Patents by Inventor Maya Maor

Maya Maor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEUROPROTECTION USING NAP-LIKE AND SAL-LIKE PEPTIDE MIMETICS
    Publication number: 20130123186
    Abstract: This invention relates to NAP-like and SAL-like peptide mimetics, polypeptides, or small molecules derived from them, and their use in the treatment of neuronal dysfunction, neurodegenerative disorders cognitive deficits, neuropsychiatric disorders, and autoimmune disease.
    Type: Application
    Filed: October 30, 2012
    Publication date: May 16, 2013
    Applicants: Allon Therapeutics Inc., Ramot at Tel-Aviv University Ltd.
    Inventors: Illana Gozes, Alistair Stewart, Maya Maor, Sharon Furman-Assaf
  • Therapeutics based on tau/microtubule dynamics
    Patent number: 8377875
    Abstract: The invention is based on the discovery of a novel neuroprotective peptide. In addition, the invention rests on the discovery that the NAP peptide enhances the association of tau and the brain-specific beta tubulin subunit. In addition, NAP modifies microtubule assembly and dynamics, in part, by affecting the tyrosination of microtubule proteins. The invention provides compositions and methods for treatment and prevention of neuronal disorders, including NAP-binding and tau-binding agents, tau peptide mimetics, NAP-like and NAP-like tau peptide mimetics.
    Type: Grant
    Filed: January 10, 2008
    Date of Patent: February 19, 2013
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Illana Gozes, Maya Maor, Saar Oz, David Dangoor, Inna Divinski
  • Neuroprotection using NAP-like and SAL-like peptide mimetics
    Patent number: 8324166
    Abstract: This invention relates to NAP-like and SAL-like peptide mimetics, polypeptides, or small molecules derived from them, and their use in the treatment of neuronal dysfunction, neurodegenerative disorders cognitive deficits, neuropsychiatric disorders, and autoimmune disease.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: December 4, 2012
    Assignees: Ramot at Tel-Aviv University, Ltd., Allon Therapeutics, Inc.
    Inventors: Illana Gozes, Alistair Stewart, Maya Maor, Sharon Furman-Assaf
  • NOVEL THERAPEUTICS BASED ON TAU/MICROTUBULE DYNAMICS
    Publication number: 20100303785
    Abstract: The invention is based on the discovery of a novel neuroprotective peptide. In addition, the invention rests on the discovery that the NAP peptide enhances the association of tau and the brain-specific beta tubulin subunit. In addition, NAP modifies microtubule assembly and dynamics, in part, by affecting the tyrosination of microtubule proteins. The invention provides compositions and methods for treatment and prevention of neuronal disorders, including NAP-binding and tau-binding agents, tau peptide mimetics, NAP-like and NAP-like tau peptide mimetics.
    Type: Application
    Filed: January 10, 2008
    Publication date: December 2, 2010
    Inventors: Illana Gozes, Maya Maor, Saar Oz, David Dangoor, Inna Divinski
  • NEUROPROTECTION USING NAP-LIKE AND SAL-LIKE PEPTIDE MIMETICS
    Publication number: 20100216723
    Abstract: This invention relates to NAP-like and SAL-like peptide mimetics, polypeptides, or small molecules derived from them, and their use in the treatment of neuronal dysfunction, neurodegenerative disorders cognitive deficits, neuropsychiatric disorders, and autoimmune disease.
    Type: Application
    Filed: February 18, 2010
    Publication date: August 26, 2010
    Applicants: Ramot at Tel-Aviv University Ltd., Allon Therapeutics Inc.
    Inventors: Illana Gozes, Alistair Stewart, Maya Maor, Sharon Furman-Assaf